Le Lézard
Classified in: Health
Subject: SVY

Chronic Obstructive Pulmonary Disease (COPD) -Epidemiology Forecast to 2025


NEW YORK, Nov. 17, 2017 /PRNewswire/ -- DelveInsight "Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Chronic Obstructive Pulmonary Disease (COPD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).

Read the full report: https://www.reportlinker.com/p05144677


It includes 10 years epidemiology historical and forecasted data of Chronic Obstructive Pulmonary Disease (COPD) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chronic Obstructive Pulmonary Disease (COPD). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report
The Report includes the prevalent population and how will it change over the next eight years.
Prevalent or incident cases segmented by age and sex.
Coverage of key Chronic Obstructive Pulmonary Disease (COPD) subpopulations and its prevalent or incident cases
The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Obstructive Pulmonary Disease (COPD) market.
Identifying prevalent patient populations as well as risk factors in the global Chronic Obstructive Pulmonary Disease (COPD) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Chronic Obstructive Pulmonary Disease (COPD) therapeutics in each of the markets covered.

Read the full report: https://www.reportlinker.com/p05144677

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 10:19
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...

at 10:17
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...

at 10:16
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...

at 10:15
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....



News published on and distributed by: